Uncovering regional atrophy not explained by tau deposition using Additional Pathology Inference (AddiPath)
We introduced AddiPath, a method for disentangling the contributions of additional pathology from primary pathology. AddiPath uncovered changes in CT not explained by tau deposition in the limbic lobe, possibly indicating TDP-43 deposition. This approach could improve patient selection for clinical trials and treatment stratification. Future work will replicate this finding across additional cohorts and test the applicability of AddiPath to other biomarkers.
Authors
- Lawrence P. Binding (ORCID: https://orcid.org/0000-0002-5658-4960)
- NP Oxtoby
- Isaac Llorente Saguer
- Mihaela Croitor
- Christopher S Parker
- Daniel C Alexander
- Alexandra L Young
Institutions
- The London College (GB)
- University College London (GB)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_105447
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00